INVASIVE BREAST CARCINOMA
Clinical trials for INVASIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chemo-resistant breast cancer? trial tests immune-boosting drug
Disease control TerminatedThis study looked at whether the drug abemaciclib could help people with triple negative breast cancer that didn't respond to standard chemotherapy. The goal was to see if the drug could change the tumor's immune environment to make it more attackable by the body's defenses. The …
Matched conditions: INVASIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Antifungal drug tested against brain tumors – trial stopped early
Knowledge-focused TerminatedThis early-phase trial tested whether the antifungal drug ketoconazole could block a protein called tGLI1 in brain tumors. It included 15 people with breast cancer that spread to the brain or with a type of brain cancer called glioma. The study was terminated early, so we have li…
Matched conditions: INVASIVE BREAST CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC